Oral tolerance: immune mechanisms and treatment of autoimmune diseases (Q41546336)

3 October 2017

1 reference

title

Oral tolerance: immune mechanisms and treatment of autoimmune diseases (English)

1 reference

3 October 2017

Weiner HL

1

1 reference

3 October 2017

1 July 1997

1 reference

3 October 2017

1 reference

3 October 2017

18

1 reference

3 October 2017

335-343

1 reference

3 October 2017

7

1 reference

The regulation of immune responses to dietary protein antigens.

3 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Effects of oral administration of type II collagen on rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Oral type II collagen treatment in early rheumatoid arthritis. A double-blind, placebo-controlled, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Three-year open protocol continuation study of oral tolerization with myelin antigens in multiple sclerosis and design of a phase III pivotal trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Oral tolerance: mechanisms and applications. Introduction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Peripheral deletion of antigen-reactive T cells in oral tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Overview of the mucosal immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Passage of undegraded dietary antigen into the blood of healthy adults. Further characterization of the kinetics of uptake and the size distribution of the antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Neonatal oral tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Oral tolerance to myelin basic protein induces regulatory TGF-beta-secreting T cells in Peyer's patches of SJL mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Oral administration of the contact sensitizer trinitrochlorobenzene: initial sensitization and subsequent appearance of a suppressor population

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4,

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

The expanding universe of T-cell subsets: Th1, Th2 and more.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

CD4+ but not CD8+ T cells are required for the induction of oral tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Peripheral tolerance of Th2 lymphocytes induced by continuous feeding of ovalbumin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Regulation of IgE responses to inhaled antigen in mice by antigen-specific gamma delta T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Anti-gamma delta T cell antibody blocks the induction and maintenance of oral tolerance to ovalbumin in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Orally induced, peptide-specific gamma/delta TCR+ cells suppress experimental autoimmune uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Antigen-driven bystander suppression after oral administration of antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Suppression of antigen-induced arthritis in Lewis rats by oral administration of type II collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Oral tolerization leads to active suppression and bystander tolerance in adult rats while anergy dominates in young rats

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Effect of oral beta interferon on subsequent immune responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Thein vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

The role of chemokines in oral tolerance. Abrogation of nonresponsiveness by treatment with antimonocyte chemotactic protein-1

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Oral-antigen delivery by way of a multiple emulsion system enhances oral tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Oral cytokine administration

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Impaired mucosal immune responses in interleukin 4-targeted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

gamma/delta T cell-deficient mice have impaired mucosal immunoglobulin A responses

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Lack of oral tolerance but oral priming for contact sensitivity to dinitrofluorobenzene in major histocompatibility complex class II-deficient mice and in CD4+ T cell-depleted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Antigen-driven peripheral immune tolerance: suppression of experimental autoimmmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Oral tolerance in EAE: reversal of tolerance by T helper cell cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Oral tolerance in experimental autoimmune encephalomyelitis: serum and salivary antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the lewis rat and strain 13 guinea pig

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Suppression of collagen induced arthritis by oral administration of type II collagen: changes in immune and arthritic responses mediated by active peripheral suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Suppression of adjuvant arthritis in rats by induction of oral tolerance to mycobacterial 65-kDa heat shock protein

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Induction of oral tolerance to S-antigen induced experimental autoimmune uveitis by a uveitogenic 20mer peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Suppression of experimental autoimmune uveitis in rats by the oral administration of the uveitopathogenic S-antigen fragment or a cross-reactive homologous peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Inhibition of experimental autoimmune uveoretinitis by oral administration of S-antigen and synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

B cell responses to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Oral administration of human insulin to NOD mice generates CD4+ T cells that suppress adoptive transfer of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Induction of Autoimmune Diabetes by Oral Administration of Autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Down-regulation of the immune response to histocompatibility antigens and prevention of sensitization by skin allografts by orally administered alloantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

The effect of oral immunization on corneal allograft survival

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Suppression of murine experimental autoimmune thyroiditis by oral administration of porcine thyroglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Selective staining of human dermal collagen. I. An analysis of standard methods.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Suppression of the immune response by nasal immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. V. Hierarchy of suppression by myelin basic protein from different species

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Induction by chronic autoimmune arthritis in DBA/1 mice by oral administration of type II collagen and Escherichia coli lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

Orally administered myelin basic protein in neonates primes for immune responses and enhances experimental autoimmune encephalomyelitis in adult animals

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901053-0

7 January 2021

10.1016/S0167-5699(97)01053-0

Identifiers

DOI

1 reference

3 October 2017

1 reference

PubMed ID

9238837